Micro-CT imaging analysis for the effect of celecoxib, a cyclooxygenase-2 inhibitor, on inflammatory bone destruction in adjuvant arthritis rats (Q43781342)

From Wikidata

Jump to navigation Jump to search

scientific article published on 30 August 2008

Language	Label	Description	Also known as
English	Micro-CT imaging analysis for the effect of celecoxib, a cyclooxygenase-2 inhibitor, on inflammatory bone destruction in adjuvant arthritis rats	scientific article published on 30 August 2008

Statements

scholarly article

1 reference

Europe PubMed Central

26 November 2017

Micro-CT imaging analysis for the effect of celecoxib, a cyclooxygenase-2 inhibitor, on inflammatory bone destruction in adjuvant arthritis rats (English)

1 reference

Europe PubMed Central

26 November 2017

author name string

Masahiro Noguchi

1

1 reference

Europe PubMed Central

26 November 2017

Aishi Kimoto

2

1 reference

Europe PubMed Central

26 November 2017

Masao Sasamata

3

1 reference

Europe PubMed Central

26 November 2017

Keiji Miyata

4

1 reference

Europe PubMed Central

26 November 2017

publication date

30 August 2008

1 reference

Europe PubMed Central

26 November 2017

Journal of Bone and Mineral Metabolism

1 reference

Europe PubMed Central

26 November 2017

26

1 reference

Europe PubMed Central

26 November 2017

5

1 reference

Europe PubMed Central

26 November 2017

461-468

1 reference

Europe PubMed Central

26 November 2017

https://scigraph.springernature.com/pub.10.1007/s00774-008-0855-3

0 references

Bone loss in inflammatory arthritis: mechanisms and treatment strategies

1 reference

https://api.crossref.org/works/10.1007%2FS00774-008-0855-3

21 January 2018

Cyclooxygenases 1 and 2

1 reference

https://api.crossref.org/works/10.1007%2FS00774-008-0855-3

21 January 2018

Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis

1 reference

https://api.crossref.org/works/10.1007%2FS00774-008-0855-3

21 January 2018

Transcriptional induction of cyclooxygenase-2 in osteoblasts is involved in interleukin-6-induced osteoclast formation.

1 reference

https://api.crossref.org/works/10.1007%2FS00774-008-0855-3

21 January 2018

Impaired bone resorption by lipopolysaccharide in vivo in mice deficient in the prostaglandin E receptor EP4 subtype

1 reference

https://api.crossref.org/works/10.1007%2FS00774-008-0855-3

21 January 2018

Prostaglandin G/H synthase-2 is required for maximal formation of osteoclast-like cells in culture

1 reference

https://api.crossref.org/works/10.1007%2FS00774-008-0855-3

21 January 2018

Impaired inflammatory and pain responses in mice lacking an inducible prostaglandin E synthase

1 reference

https://api.crossref.org/works/10.1007%2FS00774-008-0855-3

21 January 2018

An Essential Role of Cytosolic Phospholipase A2α in Prostaglandin E2–mediated Bone Resorption Associated with Inflammation

1 reference

https://api.crossref.org/works/10.1007%2FS00774-008-0855-3

21 January 2018

The role of prostaglandin E receptor subtypes (EP1, EP2, EP3, and EP4) in bone resorption: an analysis using specific agonists for the respective EPs

1 reference

https://api.crossref.org/works/10.1007%2FS00774-008-0855-3

21 January 2018

Prostaglandin E2 induced the differentiation of osteoclasts in mouse osteoblast-depleted bone marrow cells

1 reference

https://api.crossref.org/works/10.1007%2FS00774-008-0855-3

21 January 2018

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

1 reference

https://api.crossref.org/works/10.1007%2FS00774-008-0855-3

21 January 2018

Osteoprotegerin is produced when prostaglandin synthesis is inhibited causing osteoclasts to detach from the surface of mouse parietal bone and attach to the endocranial membrane.

1 reference

https://api.crossref.org/works/10.1007%2FS00774-008-0855-3

21 January 2018

Suppression of osteoprotegerin expression by prostaglandin E2 is crucially involved in lipopolysaccharide-induced osteoclast formation

1 reference

https://api.crossref.org/works/10.1007%2FS00774-008-0855-3

21 January 2018

Disease-modifying activity of SB 273005, an orally active, nonpeptide alphavbeta3 (vitronectin receptor) antagonist, in rat adjuvant-induced arthritis

1 reference

https://api.crossref.org/works/10.1007%2FS00774-008-0855-3

21 January 2018

Pharmacological analysis of cyclooxygenase-1 in inflammation

1 reference

https://api.crossref.org/works/10.1007%2FS00774-008-0855-3

21 January 2018

Enzymologic and pharmacologic profile of loxoprofen sodium and its metabolites

1 reference

https://api.crossref.org/works/10.1007%2FS00774-008-0855-3

21 January 2018

Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic

1 reference

https://api.crossref.org/works/10.1007%2FS00774-008-0855-3

21 January 2018

Valdecoxib: assessment of cyclooxygenase-2 potency and selectivity

1 reference

https://api.crossref.org/works/10.1007%2FS00774-008-0855-3

21 January 2018

Effect of celecoxib, a cyclooxygenase-2 inhibitor, on the pathophysiology of adjuvant arthritis in rat.

1 reference

https://api.crossref.org/works/10.1007%2FS00774-008-0855-3

21 January 2018

Contribution of trabecular and cortical components to the mechanical properties of bone and their regulating parameters.

1 reference

https://api.crossref.org/works/10.1007%2FS00774-008-0855-3

21 January 2018

Trabecular bone pattern factor--a new parameter for simple quantification of bone microarchitecture

1 reference

https://api.crossref.org/works/10.1007%2FS00774-008-0855-3

21 January 2018

Multi-detector row CT imaging of vertebral microstructure for evaluation of fracture risk.

1 reference

https://api.crossref.org/works/10.1007%2FS00774-008-0855-3

21 January 2018

Human osteoclast formation and activity in vitro: effects of alendronate.

1 reference

https://api.crossref.org/works/10.1007%2FS00774-008-0855-3

21 January 2018

Carbonic anhydrase inhibitors: X-ray crystallographic structure of the adduct of human isozyme II with a topically acting antiglaucoma sulfonamide

1 reference

https://api.crossref.org/works/10.1007%2FS00774-008-0855-3

21 January 2018

Unexpected nanomolar inhibition of carbonic anhydrase by COX-2-selective celecoxib: new pharmacological opportunities due to related binding site recognition

1 reference

https://api.crossref.org/works/10.1007%2FS00774-008-0855-3

21 January 2018

Suppression of adjuvant-induced arthritic bone destruction by cyclooxygenase-2 selective agents with and without inhibitory potency against carbonic anhydrase II.

1 reference

https://api.crossref.org/works/10.1007%2FS00774-008-0855-3

21 January 2018

Induction of apoptosis in rheumatoid synovial fibroblasts by celecoxib, but not by other selective cyclooxygenase 2 inhibitors

1 reference

https://api.crossref.org/works/10.1007%2FS00774-008-0855-3

21 January 2018

Akt1/Akt2 and mammalian target of rapamycin/Bim play critical roles in osteoclast differentiation and survival, respectively, whereas Akt is dispensable for cell survival in isolated osteoclast precursors

1 reference

https://api.crossref.org/works/10.1007%2FS00774-008-0855-3

21 January 2018

The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2

1 reference

https://api.crossref.org/works/10.1007%2FS00774-008-0855-3

21 January 2018

Differential direct effects of cyclo-oxygenase-1/2 inhibition on proteoglycan turnover of human osteoarthritic cartilage: an in vitro study

1 reference

https://api.crossref.org/works/10.1007%2FS00774-008-0855-3

21 January 2018

Induction of cyclooxygenase II in human synovial microvessel endothelial cells by interleukin-1. Inhibition by glucocorticoids

1 reference

https://pubmed.ncbi.nlm.nih.gov/18758904

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Development of arthritis, periarthritis and periostitis in rats given adjuvants

1 reference

https://pubmed.ncbi.nlm.nih.gov/18758904

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of methotrexate therapy on bone mineral density and body composition in rat adjuvant arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18758904

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bone destruction in arthritis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18758904

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prostaglandin endoperoxide H synthases-1 and -2.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18758904

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin-1-Induced Prostaglandin E2 Biosynthesis in Human Synovial Cells Involves the Activation of Cytosolic Phospholipase A2 and Cyclooxygenase-2

1 reference

https://pubmed.ncbi.nlm.nih.gov/18758904

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of cyclooxygenase-2 in human and an animal model of rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18758904

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum CrossLaps One Step ELISA. First application of monoclonal antibodies for measurement in serum of bone-related degradation products from C-terminal telopeptides of type I collagen

1 reference

https://pubmed.ncbi.nlm.nih.gov/18758904

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Celecoxib has a positive effect on the overall metabolism of hyaluronan and proteoglycans in human osteoarthritic cartilage

1 reference

https://pubmed.ncbi.nlm.nih.gov/18758904

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Two distinct actin-binding sites of smooth muscle calponin

1 reference

https://pubmed.ncbi.nlm.nih.gov/18758904

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Knockout of the murine prostaglandin EP2 receptor impairs osteoclastogenesis in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/18758904

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Measurement of bone degradation products in serum using antibodies reactive with an isomerized form of an 8 amino acid sequence of the C-telopeptide of type I collagen

1 reference

https://pubmed.ncbi.nlm.nih.gov/18758904

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interactive effect of interleukin-6 and prostaglandin E2 on osteoclastogenesis via the OPG/RANKL/RANK system

1 reference

https://pubmed.ncbi.nlm.nih.gov/18758904

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00774-008-0855-3

1 reference

Europe PubMed Central

26 November 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

26 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43781342&oldid=2103277105"